Gene therapy for asthma

Molecular Therapy

Volumn 7, Issue 2, 2003, Pages 148-152

  Factor, Philip ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Airway epithelium; Asthma; Gene therapy; IFN ; IL 12,; Th1; Th2; 2 adrenergic receptor

Indexed keywords

ANTIASTHMATIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; LYMPHOTOXIN; MAJOR BASIC PROTEIN; STAT4 PROTEIN; STAT6 PROTEIN; STEROID; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ALLERGIC ASTHMA; BRONCHUS HYPERREACTIVITY; CATARACT; CELL ACTIVATION; CELL DAMAGE; CELL POLARITY; CPG ISLAND; CYTOKINE PRODUCTION; EOSINOPHIL; EPITHELIUM CELL; GENE LOCUS; GENE THERAPY; GENE TRANSFER; HYPERGLYCEMIA; HYPERTENSION; IMMUNOMODULATION; IMMUNOPATHOLOGY; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION; PSYCHOSIS; RESPIRATORY EPITHELIUM; SHORT SURVEY; T LYMPHOCYTE; TH1 CELL; TH2 CELL; WEIGHT GAIN;

ALPHAVIRUS; ANIMALIA; BRONCHUS;

EID: 0037302973     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00003-0     Document Type: Short Survey

References (35)

1. Corry, D. B., and Kheradmand, F. (1999). Induction and regulation of the IgE response. Nature 402: 1318-23.
2. Hogan, S. P., Foster, P. S., Tan, X., and Ramsay, A. J. (1998). Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity. Eur. J. Immunol. 28: 413-423.
3. Lee, Y. L., et al. (2001). Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma. Hum. Gene Ther 12: 2065-2079.
4. Stampfli, M. R., et al. (1999). Regulation of allergic mucosal sensitization by interleukin-12 gene transfer to the airway. Am. J. Respir. Cell Mol. Biol. 21: 317-326.
5. del Pozo, V., et al. (2002). Gene therapy with galectin-3 inhibits bronchial obstruction and inflammation in antigen-challenged rats through interleukin-5 gene downregulation. Am. J. Respir. Crit. Care Med. 166: 732-737.
6. Bryan, S. A., et al. (2000). Effects of recombinant human interleukin-12 one eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356: 2149-2153.
7. Foster, P. S., et al. (2001). Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 179: 173-181.
8. Behera, A. K., Kumar, M., Lockey, R. F., and Mohapatra, S. S. (2002). Adenovirus-mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling. Hum. Gene Ther. 13: 1697-1709.
9. Li, X. M., et al. (1996). Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J. Immunol. 157: 3216-3219.
10. Dow, S. W., Schwarze, J., Heath, T. D., Potter, T. A., and Gelfand, E. W. (1999). Systemic and local interferon gamma gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in mice. Hum. Gene Ther. 10: 1905-1914.
11. Walter, D. M., et al. (2001). II-18 gene transfer by adenovirus prevents the development of and reverses established allergen-induced airway hyperreactivity. J. Immunol. 166: 6392-6398.
12. Zavorotinskaya, T., Tomkinson, A., and Murphy, J. E. (2003). Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13. Journal vol: pages.
13. Tomkinson, A., et al. (2001). A murine receptor antagonist that inhibits IL-4 and IL-13 -induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J. Immunol. 166: 5792-5800.
14. Kotsimbos, T. C., et al. (1998). Expression of the IL-4 receptor alpha-subunit is increased in bronchial biopsy specimens from atopic and nonatopic asthmatic subjects. J. Allergy Clin. Immunol. 102: 859-866.
15. Oh, J. W., et al. (2002). CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. J. Allergy Clin. Immunol. 110: 460-468.
16. Stampfli, M. R., et al. (1999). Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice. Am. J. Respir. Cell Mol. Biol. 21: 586-596.
17. Makela, M. J., et al. (2000). IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc. Natl. Acad. Sci. USA 97: 6007-6012.
18. Kline, J. N., Kitagaki, K., Businga, T. R., and Jain, V. V. (2002). Treatment of established asthma in a murine model using CpG oligodeoxynucleotides. Am. J. Physiol. Lung Cell Mol. Physiol. 283: L170-179.
19. Jain, V. V., et al. (2002). CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J. Allergy Clin. Immunol. 110: 867-872.
20. Kitagaki, K., Jain, V. V., Businga, T. R., Hussain, I., and Kline, J. N. (2002). Immunomodulatory effects of CpG oligodeoxynucleotides on established th2 responses. Clin. Diagn. Lab Immunol. 9: 1260-1269.
21. Broide, D., et al. (1998). Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 161: 7054-7062.
22. Finotto, S., et al. (2002). Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295: 336-338.
23. Hansen, G., et al. (2000). CD4(+) T helper cells engineered to produce latent TGF-betal reverse allergen-induced airway hyperreactivity and inflammation. J. Clin. Invest. 105: 61-70.
24. McGraw, D. W., et al. (2001). Targeted transgenic expression of beta(2)-adrenergic receptors to type II cells increases alveolar fluid clearance. Am. J. PhysioL Lung Cell Mol. Physiol. 281: L895-903.
25. Small, K. M., Brown, K. M., Forbes, S. L., and Liggett, S. B. (2001). Modification of the beta 2-adrenergic receptor to engineer a receptor-effector complex for gene therapy. J. Biol. Chem. 276: 31596-31601.
26. 2-adrenergic receptor attenuates airway reactivity in mice. Mol. Ther. 5: S162.
27. Nyce, J. W., and Metzger, W. J. (1997). DNA antisense therapy for asthma in an animal model. Nature 385: 721-725.
28. Nakanishi, A., et al. (2001). Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc. Natl. Acad. Sci. USA 98: 5175-5180.
29. Mathieu, M., et al. (1999). The glucocorticoid receptor gene as a candidate for gene therapy in asthma. Gene Ther. 6: 245-252.
30. Folkerts, G., and Nijkamp, F. P. (1998). Airway epithelium: more than just a barrier! Trends Pharmacol. Sci. 19: 334-341.
31. Walters, R. W., et al. (1999). Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J. Biol. Chem. 274: 10219-10226.
32. Seiler, M. P., et al. (2002). Thixotropic solutions enhance viral-mediated gene transfer to airway epithelia. Am. J. Respir. Cell Mol. Biol. 27: 133-140.
33. Fasbender, A., et al. (1998). Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J. Clin. Invest. 102: 184-193.
34. Gregory, L. G., et al. (2003). Enhancement of adenovirus-mediated gene transfer to the airways by DEAE dextran and sodium caprate in vivo. Mol. Ther. 7: pages.
35. Factor, P., Mendez, M., Mutlu, G. M., and Dumasius, V. (2002). Acute hyperoxic lung injury does not impede adenoviral-mediated alveolar gene transfer. Am. J. Respir. Crit. Care Med. 165: 521-526.